Tag: NTRA

Natera, a leading company specializing in cell-free DNA testing, has announced its endorsement of the 2024 Clinical Practice Guideline established ...

On January 30, 2024, Matthew Sykes, an analyst at Goldman Sachs, expressed his bullish sentiment towards Natera (NASDAQ: NTRA) by ...